Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionVident Advisory, LLC
Latest Disclosed Ownership27,604 shares
Latest Disclosed Value $ 9,712,600
Vident Advisory, LLC reports 50.41% increase in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Vident Advisory, LLC filed a 13F-HR form disclosing ownership of 27,604 shares of Amgen Inc. (MX:AMGN) valued at $9,712,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 18,352 shares of Amgen Inc.. This represents a change in shares of 50.41% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 27,604 9,252 50.41 9,713 61.70 0.0263
2026-02-18 2025-12-31 13F AMGEN COM 031162100 18,352 -1,382 -7.00 6,007 7.87 0.0547
2025-11-14 2025-09-30 13F AMGEN COM 031162100 19,734 1,468 8.04 5,569 9.18 0.0532
2025-08-14 2025-06-30 13F AMGEN COM 031162100 18,266 417 2.34 5,100 -8.29 0.0573
2025-05-15 2025-03-31 13F AMGEN COM 031162100 17,849 -1,482 -7.67 5,562 10.38 0.0813
2025-02-14 2024-12-31 13F AMGEN COM 031162100 19,331 12,250 173.00 5,039 120.87 0.0884
2024-11-14 2024-09-30 13F AMGEN COM 031162100 7,081 1,757 33.00 2,282 37.16 0.0574
2024-08-14 2024-06-30 13F AMGEN COM 031162100 5,324 -110,182 -95.39 1,663 -94.94 0.0460
2024-05-14 2024-03-31 13F AMGEN COM 031162100 115,506 47,918 70.90 32,841 68.70 0.6841
2024-02-14 2023-12-31 13F AMGEN COM 031162100 67,588 -12,605 -15.72 19,467 -9.68 0.4893
2024-02-21 2023-09-30 13F/A-01 AMGEN COM 031162100 80,193 80,193 21,553 0.6677
2023-11-14 2023-09-30 13F AMGEN COM 031162100 80,193 80,193 21,553 0.5377
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.